Effect of organic mercury exposure during early stage of ontogenic development on the central dopaminergic system in adult rats

• Autorzy: Durczok A , Szkilnik R. , Brus R. , Nowak P. , Labus L. , Konecki J. , Drabek K. , Kuballa G. , Rycerski W. , Mengel K.
• Języki publikacji: EN

Abstrakty

EN

Organic mercury (CH3HgCl) with metal concentration 5 ppm in tap water was applied to rats suckling their newborn for the first 21 days of life. A second group of young rats took the mercury in their tap water 5 ppm from the 22nd to the 43rd day of postnatal life. Control rats drank tap water only. In 2-month-old male rats the following behavioral study was performed after saline or specific central dopamine receptor agonists and agonists apply (quinpirole, SKF-38393, haloperidol, SCH-23390): irritability, yawning behavior, oral activity, locomotion, exploratory activity, and catalepsy. In the striatum and frontal cortex of three examined groups the biogenic amines levels (DA, DOPAC, HVA, 3-MT, 5-HT, 5-HIAA, NA) were estimated by means of HPLC/ED technique, and DA and 5-HT turnover. The effect of quinpirole (a central dopamine D2 receptor agonists) was also examined on (3H)glucose uptake in discrete parts of the brain. It was shown that mercury affected behavioral changes after dopaminergic agents apply to adult animals when exposed in the period from the 22nd to 43rd day of postnatal development. Biochemical changes (biogenic amines level, turnover and (3H)glucose uptake) were more pronounced in adult animals exposed to mercury via mother's milk (1st to 21st day of life). In light of the above we conclude that early postnatal exposure of rats to organic mercury modulates activity of the central dopamine neurotransmitter system.

Słowa kluczowe

EN

central dopaminergic system; behaviour; metal concentration; man; biogenic amine; ontogenetic development; organic mercury; animal; mercury exposure; rat; adult; neurotoxic agent

• Wydawca: -
• Czasopismo: Polish Journal of Environmental Studies
• Rocznik: 2002
• Tom: 11
• Numer: 4
• Opis fizyczny: p.307-314,fig.

Twórcy

autor

Durczok A

• Medical University of Silesia, H.Jordana 38, 41-808 Zabrze, Poland

autor

Szkilnik R.

autor

Brus R.

autor

Nowak P.

autor

Labus L.

autor

Konecki J.

autor

Drabek K.

autor

Kuballa G.

autor

Rycerski W.

autor

Mengel K.

Bibliografia

• 1. AMIN-ZAKI L., EL-HASSANI S., MAJEED M.A., CLAR KSON T.W., DOHERTY R.A., GREENWOOD K.R. Studies of infants postnatally exposed to methylmercury. J. Pediatr. 85, 81, 1974.
• 2. ARCHER T. Behavioral retardation in the neuropathology of neonatal retardation. APMIS (Suppl.) 40, 35, 1993.
• 3. ARCHER T., FREDRIKSON A. Functional changes implicating dopaminergic system following perinatal treatments. Der. Pharmacol. Ther. 18, 201, 1992.
• 4. ASCHNER M., KIMELBERG H.K. Astrocytes: Potential modulators of heavy metal-induced neurotoxicity. In: Toxi cology of Metals. Biochemical Aspects. (Goyer R.A., Cher- ian M.G. eds.). Sringer-Verlag 587-608, 1996.
• 5. BAKIR F., DAMLUJI S.F., AMIN-ZAKI L., MARTADHA M., KHALIDI A., AL-RAWI N.Y, TIKRITI S, DHAHIR HI., CLARKSON T.W, SMITH J.C., DOHERTY R.A. Methylmercury poisoning in Iraq. Science 181, 230, 1973.
• 6. BERGMAN M. Side-effects of amalgam and its alternatives: local, systemic and environmental. Int. Dent. J. 40, 4, 1990.
• 7. CAGIANO R., DE SALVIA M.A., RENNA G., TOR­TELLA E., BRAGHIROLI D., PARENTI C, ZANOLI P., BARDOLINI M, ANNAU Z, CUOMO V. Evidence that exposure to methyl mercury during gestation induces behavioral and neurochemical changes in offspring of rats. Neurotoxicol. Teratol. 12, 23, 1990.
• 8. CARLSON A., DAVISON J.N., KEHR W., LINDQUIST M., ATACK C.V. Simultaneous measurement of tyrosine and tryptophan-hydroxylase activity in brain in vivo, using an inhibitor of the aromatic amino acid decarboxylase. Nan- nyn-Schmiedeberg's Arch. Pharmacol. 275, 153, 1972.
• 9. CLARKSON T.W. Pharmacology of mercury compounds. Ann. Rev. Pharmacol. 12, 375, 1972.
• 10. CLARKSON T.W. Mercury toxicity. In Essential and Toxic Trace Elements in Human Health and Disease. Alan R. Liss, Inc. pp 631-643, 1988.
• 11. CUOMO V, AMBROSI L., ANNAN Z., CAGIANO R, BRUNELLO N., RACAGNI G. Behavioral and neurochemical changes in offspring of rats exposed to methyl mercury during gestation. Neurobehav. Toxicol. Teratol. 6, 249, 1984.
• 12. FILE S.E., POPE J.H. The action of chlorpromazine on ex ploration in pairs of rats. Psychopharmacol. 37, 249, 1974.
• 13. GONG L., KOSTRZEWA R.M., FULLER R.W., PERRY K.W. Supersensitization of the oral response to SKF-38393 in neonatal 6-hydroxy-dopamine-lesioned rats is mediated through a serotonine system. J. Pharmacol. Exp. Ther. 261, 1000, 1992.
• 14. GOYER R.A. Toxic effects of metal. In: Casarret and Doull's Toxicology. The Basic Science of Poisoning. (Amdur M.D., Doull J., Klassen D.D., eds.). Pergamon Press, 623-680, 1991.
• 15. GREENWOOD M.R., CLARKSON T.W., DOHERTY R.A., GATES A.H., AMIN-ZAKI L., EL-HASSANI S., MAJEED M.A. Blood clearance half-time in lactating and non-lactating members of a population exposed to methyl mercury. Environ. Res. 16, 48 (abstract), 1978.
• 16. HAMADA R, ARIMURA K, OSAME M. Maternal-fetal mercury transport and fetal methylmercury poisoning, In Metal Ions in Biological Systems (Sigel A and Sigel H, eds.). Marcel Dekker Inc., pp 405-420, 1997.
• 17. HAMADA R., OSAME M. Minamata disease and other mercury syndrome. In: Toxicology of Metals (Chang L.W., ed.), Lewis Publishers, 337-351, 1996.
• 18. KERPER L.E., BALLATORI N., CLARKSON T.W. Methylmercury transport across the blood brain barrier by an amino acid carrier. Am. J. Physiol. 262, R761, 1992.
• 19. KISZKA W, SZKILNIK R., DURCZOK A., BRUS R. Re activity of the central dopamine receptors in rats prenatally exposured to mercury, estimated by behavioral methods. Conference on Metabolism of Drugs and Xenobiotics. Bukowina-Tatrzanska, May 31 - June 2. Abstract Book 19 (Abstract P-I-3), 2000.
• 20. KLASSEN CD. Heavy metals and heavy-metal antagonists. In: Goodman and Gilman;s The Pharmacological Basis of Therapeutics (Hardman L.E., ed.) McGraw-Hill, 1649-1671, 1995
• 21. KOSTRZEWA R.M., BRUS R. Is dopamine-agonist in duced yawning behavior a D3 mediated event? Life Sci. 48, PL-129, 1991.
• 22. KOSTRZEWA R.M., BRUS R. Ontogenic homologous supersensitization of quinpirole-induced yawning in rats. Pharmacol. Biochem. Behav. 39, 517, 1991.
• 23. KOSTRZEWA R.M., GONG I. Supersensitized D, recep tors mediate enhanced oral activity after neonatal 6-OH-dopamine. Pharmacol. Biochem. Behav. 39, 677, 1991.
• 24. KOSTRZEWA R.M., KASTIN A.J. Tyramine-MIF-1 at tenuates development of tolerance to spiperone-induced catalepsy in rats. Brain Res. Bull. 31, 707, 1993.
• 25. KUHNERT P.M., KUHNERT B.R., ERHARD P. Comparison of mercury levels in maternal blood, fetal cord blood, and placental tissues. Am. J. Obstet. Gynecol. 139, 209, 1981.
• 26. LEHOTZKY K., SZEBERENYI J.M., UNGRARY G., KISS A. Behavioral effects of prenatal methoxy-ethyl-mer- cury chloride exposure in rat pup. Neurotoxicol. Teratol. 10, 471, 1988.
• 27. LUND B.O., MILLER D.M., WOODS J.S. Mercury-in duced H2O2 production and lipid peroxidation in vivo in rat kidney mitochondria. Biochem. Pharmacol. 11, S181, 1991.
• 28. MAGNUSSON O., NILSSON L., WESTERLAND D. Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenate in a liquid chromatography-elec- trochemical detection system. J. Chromatogr. 221, 237, 1980.
• 29. MASSARO E.J. The developmental cytotoxicity of mercurials. In: Toxicology of Metals. Biochemical Aspects (Goyer R.A. and Cherian M.G., eds.). Springer-Verlag, pp 1047-1081, 1996.
• 30. MOGOS L., HALBACH S., CLARKSON T.W. Role of catalase in the oxidation of mercury vapor. Biochem. Pharmacol. 27, 1373, 1978.
• 31. MURRAY A.M., WADDINGTON J.L. The induction of grooming and vacuous chewing by a series of selective Dl dopamine receptor agonists; two directions of D!/D2 interaction. Eur. J. Pharmacol. 160, 377, 1989.
• 32. NAKAMURA K, THOENEN H. Increased irritability, a permanent behavior change induced in the rat by intraventricular administration of 6-OH-dopamine. Psychopharm. 24, 359, 1972.
• 33. NOWAK P., KISZKA W., SZKILNIK R., BRUS R., KONECKI J. Biogenic amines level and (3H)glucose uptake in the brain of rats prenatally exposured to mercury. Confer­ence on Metabolism of Drugs and Xenobiotics. Bukowina Tatrzanska, May 31 - June 2. Abstract Book 20 (Abstract No. P-I-4), 2000.
• 34. REYNOLDS W.A., PITKIN R.M. Trans-placental passage of methyl-mercury acid and its uptake by primate fetal tis sues. Proc. Soc. Exp. Biol. Med. 148, 523, 1975.
• 35. RODGERS D.A., HOLSON R.R., FERGUSON S.A, ALI S.F., SOLIMAN M.R.I. Effects of mercuric chloride expo sure in rats. Part I. Behavioral changes observed during open field, and complex maze evaluation. Arch. Environm. Con- tam. Toxicol. 28, 17, 1996.
• 36. SKERFVING S. Mercury in women exposed to methylmer- cury through fish consumption, and their newborn babies and breast milk. Bull. Environ. Contam. Toxicol. 41, 475, 1988.
• 37. WAGNER J., VITALI P., PELFREYMAN M.G, ZRAIKA M., HOUT S. Simultaneous determination of 3,4-dihyd- roxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hy- droxy-3-methoxyphenylalanine, norepinephrine, 3,4-dihyd- roxyphenylacetic acid, homovanillic acid, serotonine, and 5-hydroxy-indolacetic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. J. Neurochem. 38, 1241, 1982.
• 38. WARKANY J, HUBBARD D.M. Mercury in the urine of children. Lancet 1, 829, 1948.
• 39. ZANOLI P., TRUZZI C, VENERI C, BRAGHIROLI D, BARALDI M. Methylmercury during late gestation affects temporarily the development of cortical muscarinic recep tors in rat offspring. Pharmacol. Toxicol. 75, 261, 1994.